Table 1 Distribution of patients per treatment strategy and number of cycles
Treatment | |||||
|---|---|---|---|---|---|
DOX 75 (N = 948) | DOX 50—IFO 5 (N = 614) | DOX 75—IFO 5 (N = 266) | DOX 75—IFO 10 (N = 217) | Total (N = 2045) | |
Number of patients with at least 6 cycles | 403 (42.5) | 270 (44.0) | 103 (38.7) | 118 (54.4) | 895 (43.7) |
Progression before/at end of treatment | 67 (16.6) | 55 (20.4) | 15 (14.6) | 9 (7.6 | 146 (16.3) |
No progression before/at end of treatment | 336 (83.4) | 215 (79.6) | 88 (85.4) | 109 (92.4) | 748 (83.6) |
Number of patients with less than 6 cycles | 545 (57.4) | 344 (56.0) | 163 (61.3) | 99 (45.6) | 1151 (56.3) |
Progression before/at end of treatment | 312 (57.2) | 175 (50.9) | 52 (31.9) | 28 (28.3) | 567 (49.3) |
No progression before/at end of treatment | 233 (42.8) | 168 (49.1) | 111 (68.1) | 71 (71.7) | 584 (50.7) |